# Factors associated with survival after pediatric in-hospital cardiac arrest: A national database analysis 2015–2022

**Authors:** Rattapon Uppala, Phanthila Sitthikarnkha, Sirapoom Niamsanit, Kaewjai Thepsuthammarat, Leelawadee Techasatian, Suchaorn Saengnipanthkul, Pope Kosararaksa, Sysavanh Nanthavongsa, Akihiro Nishi

PMC · DOI: 10.1371/journal.pone.0341430 · PLOS One · 2026-03-02

## TL;DR

This study analyzed pediatric in-hospital cardiac arrest in Thailand from 2015 to 2022, finding that nearly a third of survivors died after discharge, with metabolic issues and organ dysfunction linked to higher long-term mortality.

## Contribution

The study provides novel insights into long-term outcomes and risk factors for post-discharge mortality in pediatric cardiac arrest in a middle-income country.

## Key findings

- The incidence of pediatric in-hospital cardiac arrest in Thailand decreased from 1.8 to 1.2 per 1,000 admissions between 2015–2016 and 2022.
- 29.6% of survivors died after discharge, with metabolic acidosis and hypoglycemia strongly associated with long-term mortality.
- Diagnoses like disseminated intravascular coagulation and acute liver failure were also significantly linked to increased post-discharge mortality.

## Abstract

Pediatric in-hospital cardiac arrest (IHCA) is frequently fatal, and evidence from middle-income settings needed to guide quality improvement is sparse. We used nationwide Thai data to quantify incidence and mortality trends, describe long-term outcomes, and identify associated factors for post-discharge death after pediatric IHCA.

We performed a retrospective cohort study using the Thai National Health Security Office database encompassing all hospitalizations under the universal health-coverage scheme from 1 January 2015–31 December 2022. Children <18 years with IHCA were identified by ICD-10-TM codes I46.0/I46.1/I46.9 plus at least one resuscitation procedure code (ICD-9-CM 99.60/99.62/99.63). All-cause mortality through 31 December 2023 was obtained via linkage to the national civil registry.

Among 13.2 million pediatric admissions, 20,590 IHCAs were recorded (incidence 1.57/1,000). Incidence declined from 1.8/1,000 in 2015–2016 to 1.2/1,000 in 2022. In-hospital mortality was 62.7% (12,905/20,590). Of 7,253 survivors with follow-up (median 67 months), 2,149 (29.6%) died post-discharge. Multivariable analysis identified metabolic acidosis (adjusted hazard ratio [aHR] 1.50; 95% confidence interval [CI] 1.32–1.71) and hypoglycemia (aHR 1.54; 95% CI 1.25–1.89) as significant associated diagnoses with long-term mortality. Furthermore, diagnoses consistent with severe organ dysfunction, including disseminated intravascular coagulation (aHR 1.51; 95% CI 1.24–1.85), acute liver failure (aHR 1.42; 95% CI 1.10–1.84), and anoxic brain injury (aHR 1.23; 95% CI 1.05–1.44), were also significantly correlated with increased mortality; however, the timing of these diagnoses relative to the cardiac arrest could not be determined.

Pediatric IHCA in Thailand remains highly fatal despite recent declines in incidence and in-hospital mortality. During a median follow-up of 67 months, nearly one-third of survivors died after discharge, underscoring the substantial long-term mortality burden. Metabolic derangements and organ dysfunction were strongly associated with post-discharge mortality, highlighting the need for targeted strategies to improve both survival and long-term outcomes.

## Linked entities

- **Diseases:** disseminated intravascular coagulation (MONDO:0001243), acute liver failure (MONDO:0019542), hypoglycemia (MONDO:0004946), metabolic acidosis (MONDO:0000440)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** hyperkalemia (MESH:D006947), critically ill (MESH:D016638), injuries (MESH:D014947), circulatory collapse (MESH:D012769), IHCA (MESH:D058687), electrolyte imbalances (MESH:D014883), Cardiac Arrest (MESH:D006323), acute renal failure (MESH:D058186), sudden cardiac death (MESH:D016757), Organ dysfunctions (MESH:D009102), anoxic brain damage (MESH:D002534), acute respiratory failure (MESH:D012131), hypoxia (MESH:D000860), Pulmonary embolism (MESH:D011655), Metabolic derangements (MESH:D008659), apnea (MESH:D001049), brain injury (MESH:D001930), death (MESH:D003643), Hypothermia (MESH:D007035), hypovolemia (MESH:D020896), Metabolic acidosis (MESH:D000138), chest (MESH:D013898), acute liver failure (MESH:D017114), Tension pneumothorax (MESH:D011030), Hypoglycemia (MESH:D007003), coagulation disorders (MESH:D001778), cardiac dysfunction (MESH:D006331), Hypokalemia (MESH:D007008), hepatic involvement (MESH:D056486), sepsis (MESH:D018805), illness (MESH:D002908), DIC (MESH:D004211)
- **Chemicals:** glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12952616/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12952616/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12952616/full.md

---
Source: https://tomesphere.com/paper/PMC12952616